[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349033-105":59,"doc-detail-349033-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","burden-of-33-malignant-tumor-groups-in-5-socio-demographic-index-areas-and-21-regions-from-1990-to-2041","Burden of 33 malignant tumor groups in 5 socio-demographic index areas and 21 regions from 1990 to 2041","","Cancer and other noncommunicable diseases (NCDs) are a growing development challenge, with progress toward the UN Political Declaration hinging on localized cancer epidemiology data. Using GBD 2021, the study estimated malignant tumor burden and trends across 5 SDI areas and 21 regions (1990–2021) and projected to 2041 for 33 tumor groups. In 2021, 23.4 million new cases, 9.8 million deaths, and 251 million DALYs were attributed to malignant tumors.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/burden-of-33-malignant-tumor-groups-in-5-socio-demographic-index-areas-and-21-regions-from-1990-to-2041/349033/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/burden-of-33-malignant-tumor-groups-in-5-socio-demographic-index-areas-and-21-regions-from-1990-to-2041/349033.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn Holloway","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the main objective of the study?","Question",{"text":113,"@type":114},"To estimate global malignant tumor burden and trends across 5 socio-demographic index (SDI) areas and 21 regions from 1990–2021, and project trends to 2041 using GBD 2021 data for 33 tumor groups.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What did the study find for malignant tumor burden in 2021?",{"text":118,"@type":114},"In 2021, there were 23.4 million new cases, 9.8 million deaths, and 251 million DALYs attributable to malignant tumors, ranking third globally for DALYs after respiratory infections and tuberculosis.",{"name":120,"@type":111,"acceptedAnswer":121},"How did the projections to 2041 differ across cancer types?",{"text":122,"@type":114},"Projections indicated decreasing age-standardized incidence rates and case numbers for stomach and esophageal cancers, while increasing incidence rates and case numbers were projected for CRC, breast cancer, prostate cancer, lip/oral cavity cancer, multiple myeloma, thyroid cancer, and testicular cancer.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},349033,1790182595,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336474466712,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Original research article  \nBurden of 33 malignant tumor groups in 5 socio-demographic index areas and  \n21 regions from 1990 to 2041  \nScience Progress Vol. 109(2): 1–14 © The Author(s) 2026 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)  \n[DOI: 10.1177/00368504261443064](DOI: 10.1177/00368504261443064)  \n[journals.sagepub.com/home/sci](journals.sagepub.com/home/sci)  \nChengyun Dou1 , Yidan Sang2 , Lirong Huang3 , and Chuangjie Cao4   \nAbstract  \nObjective: Cancer and other noncommunicable diseases (NCDs) are increasingly recognized as a global development challenge. The most recent UN high-level meeting on NCDs underscored insufficient progress toward the Political Declaration on NCDs. Key barriers—including gaps in situational analysis, priority setting, and budgeting—all hinge on localized cancer epidemiology data. The Global Burden of Disease (GBD) study is uniquely positioned to provide this essential information. Methods: This study estimated global malignant tumor burden and trends across 5 socio-demographic index (SDI) areas and 21 regions from 1990-2021 and projected trends to 2041 using GBD 2021 data for 33 tumor groups. Results: In 2021, there were 23.4 million (95% UI: 22.3-23.6 million) new cases, 9.8 million (9 .1-10.5 million) deaths, and 251 million (235- 268 million) DALYs attributable to malignant tumors, ranking them third globally for DALYs after respiratory infections and tuberculosis. Tracheal, bronchus, and lung (TBL) cancer was the leading cause of cancer mortality in both genders combined (15/21 regions) and in males (14/21 regions), while breast cancer led female mortality (12/21 regions) . In high-SDI areas, malignant tumors ranked first for DALYs. TBL, colon and rectum cancer (CRC), and breast cancer comprised the top three DALY causes for both genders combined and for females; for high-SDI males, the top three were TBL, CRC, and pancreatic cancer. Projections to 2041 (Bayesian age-period-cohort [BAPC] model) indicated decreasing age-standardized incidence rates (ASIR) and case numbers for stomach and esophageal cancers. Conversely, rising ASIR and incidence numbers were projected for CRC, breast cancer, prostate cancer, lip/oral cavity cancer, multiple myeloma, thyroid cancer, and testicular cancer. Conclusions: The cancer burden profile is strongly influenced by SDI level and gender, with high-SDI regions characterized by TBL and CRC, while lower-SDI regions face a higher burden from gender-specific and infection-related cancers. TBL cancer remains the dominant driver of cancer mortality worldwide, particularly among males. Breast cancer shows remarkable consistency as the leading female-specific cancer across most regions by both incidence and mortality.  \nKeywords  \nmalignant tumor, socio-demographic index, global burden disease, trends, projection, cancer  \nReceived: 9 November 2025; Revised: 6 March 2026; Accepted: 30 March 2026  \n1Department of Infectious Diseases, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China 2College of Life Science, Shaanxi Normal University, Xi’an, Shanxi, China  \n3Hunan Polytechnic of Environment and Biology, Hengyang, Hunan, China  \n4Department of Pathology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China  \nCorresponding author:  \nChuangjie Cao, Department of Pathology, the First Affiliated Hospital, Hengyang Medical School, University of South China, No. 69 Chuanshan Road, Hengyang, Hunan 421001, China.  \nEmail: [2018012431@usc.edu.cn](2018012431@usc.edu.cn)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  \nAttribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use, reproduction and distribution of the work without further permis","cbCaib6dD15goVGm","https://ap.wps.com/l/cbCaib6dD15goVGm","pdf",3264066,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusions","[{\"question\":\"What was the main objective of the study?\",\"answer\":\"To estimate global malignant tumor burden and trends across 5 socio-demographic index (SDI) areas and 21 regions from 1990–2021, and project trends to 2041 using GBD 2021 data for 33 tumor groups.\"},{\"question\":\"What did the study find for malignant tumor burden in 2021?\",\"answer\":\"In 2021, there were 23.4 million new cases, 9.8 million deaths, and 251 million DALYs attributable to malignant tumors, ranking third globally for DALYs after respiratory infections and tuberculosis.\"},{\"question\":\"How did the projections to 2041 differ across cancer types?\",\"answer\":\"Projections indicated decreasing age-standardized incidence rates and case numbers for stomach and esophageal cancers, while increasing incidence rates and case numbers were projected for CRC, breast cancer, prostate cancer, lip/oral cavity cancer, multiple myeloma, thyroid cancer, and testicular cancer.\"}]","Burden of 33 malignant tumor groups in 5 socio-demographic index areas and 21 regions from 1990 to 2041 | PDF",1790081283,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a7038c6e818d59e25b60a168731207ef.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f0897c10170f1051e25c012215746772.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2fd9872230a6f0288c38e57dd24ad76b.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/10206310ae0b3850524336b5154df833.webp",980,1306]